CPBTD
PCRX icon

Central Pacific Bank - Trust Division’s Pacira BioSciences PCRX Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,268
Closed -$122K – 929
2024
Q2 		$122K Buy
+4,268
New +$121K 0.01% 632

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Central Pacific Bank - Trust Division's PCRX Position: Q3 2024 in Review

Central Pacific Bank - Trust Division sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 4,268 shares — an estimated $122K sold.

Central Pacific Bank - Trust Division first reported a position in PCRX in Q2 2024 and held it in 1 quarter. The position peaked at $122K in Q2 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Central Pacific Bank - Trust Division reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 4,268 Pacira BioSciences shares in Q3 2024, an estimated $122K.
  • Central Pacific Bank - Trust Division first reported a position in Pacira BioSciences in Q2 2024 and held it in 1 quarter.
  • Central Pacific Bank - Trust Division's Pacira BioSciences position peaked at $122K in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2024, filed 2 Oct 2024.